Cited by 943Colorectal Cancer Surgical TreatmentsColorectal and Anal CarcinomasPelvic floor disorders treatments

Late Side Effects of Short-Course Preoperative Radiotherapy Combined With Total Mesorectal Excision for Rectal Cancer: Increased Bowel Dysfunction in Irradiated Patients—A Dutch Colorectal Cancer Group Study

Open access
Peeters, K.C.M.J., van de Velde, C.J.H., Leer, J.W.H., Martijn, H., Junggeburt, J.M.C., Kranenbarg, E. Klein, Steup, W.H., Wiggers, T. +2 more·2005·Journal of Clinical Oncology

Abstract

Purpose: Preoperative short-term radiotherapy improves local control in patients treated with total mesorectal excision (TME). This study was performed to assess the presence and magnitude of long-term side effects of preoperative 5 × 5 Gy radiotherapy and TME. Also, hospital treatment was recorded for diseases possibly related to late side effects of rectal cancer treatment. Patients and Methods: Long-term morbidity was assessed in patients from the prospective randomized TME trial, which investigated the efficacy of 5 × 5 Gy before TME surgery for mobile rectal cancer. Dutch patients without recurrent disease were sent a questionnaire. Results: Results were obtained from 597 patients, with a median follow-up of 5.1 years. Stoma function, urinary function, and hospital treatment rates did not differ significantly between the treatment arms. However, irradiated patients, compared with nonirradiated patients, reported increased rates of fecal incontinence (62% v 38%, respectively; P < .001), pad wearing as a result of incontinence (56% v 33%, respectively; P < .001), anal blood loss (11% v 3%, respectively; P = .004), and mucus loss (27% v 15%, respectively; P = .005). Satisfaction with bowel function was significantly lower and the impact of bowel dysfunction on daily activities was greater in irradiated patients compared with patients who underwent TME alone. Conclusion: Although preoperative short-term radiotherapy for rectal cancer results in increased local control, there is more long-term bowel dysfunction in irradiated patients than in patients who undergo TME alone. Rectal cancer patients should be informed on late morbidity of both radiotherapy and TME. Future strategies should be aimed at selecting patients for radiotherapy who are at high risk for local failure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2005.14.779

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There was no significant difference between preoperative chemoradiotherapy and preoperative radiotherapy alone in sphincter preservation or survival rate.

    “and there was no significant difference between the two groups in terms of sphincter preservation or survival rate [111–118].”

    From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [114]

    The Introduction reports no difference in overall survival in a radiotherapy-and-TME trial, but it does not compare preoperative chemoradiotherapy with radiotherapy alone. The Discussion mentions sphincter-saving surgery without reporting a between-group difference in sphincter preservation. The claimed treatment comparison and sphincter-preservation result are therefore unsupported by this copy. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Incidences of sexual dysfunction and bowel dysfunction were higher in the preoperative radiation combination therapy group than in the surgery-alone group.

    “The incidences of sexual dysfunction and bowel dysfunction were higher in the preoperative radiation combination therapy group than in the surgery-alone group [113, 114].”
  • Pathologic complete response rates were significantly higher in the preoperative chemoradiotherapy groups than in the preoperative radiotherapy alone groups.

    “but the pathologic complete response rates (pCR) were significantly higher than in the preoperative radiotherapy alone groups.”

    From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [114]

    The Introduction discusses preoperative radiotherapy and local recurrence, while the Discussion focuses on late bowel dysfunction; neither reports pathologic complete response rates. Searches for pCR and for a comparison of preoperative chemoradiotherapy with radiotherapy alone found no passage addressing the claimed difference. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • In Europe, four randomized controlled trials were performed to investigate the usefulness of adding chemotherapy to preoperative radiotherapy.

    “In Europe, four randomized controlled trials, including the EORTC trial, were performed to investigate the usefulness of adding chemotherapy to preoperative radiotherapy.”

    From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [114]

    The Introduction discusses randomized trials of radiotherapy, and Study Population describes a trial comparing preoperative radiotherapy plus surgery with surgery alone. Neither section says that four European trials, including an EORTC trial, investigated adding chemotherapy to preoperative radiotherapy. Searches for that trial count and for chemotherapy combined with preoperative irradiation found no supporting passage in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • In two trials, the local recurrence rate was significantly lower in the preoperative chemoradiotherapy group than in the preoperative radiotherapy alone group.

    “In two trials, the exception being the short-course radiotherapy trial, the local recurrence rate was significantly lower in the preoperative chemoradiotherapy group”

    From Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2018) · cites this paper as [114]

    The Introduction reports lower local recurrence with preoperative radiotherapy than with surgery alone, and the Study Population describes a trial of radiotherapy plus total mesorectal excision versus excision alone. Neither passage addresses two trials comparing preoperative chemoradiotherapy with preoperative radiotherapy alone; searches for that comparison and for chemotherapy found no such result in our copy. (LLM, conf=0.77)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Peeters, K. C. M. J., van de Velde, C. J. H., Leer, J. W. H., Martijn, H., Junggeburt, J. M. C., Kranenbarg, E. K., Steup, W. H., Wiggers, T., Rutten, H. J., & Marijnen, C. A. M.
Affiliations
  • University Medical Center Groningen (NL)
  • From the Departments of Surgery and Clinical Oncology, Leiden University Medical Center, Leiden; Department of Radiotherapy, St. Radboud University Medical Center, Nijmegen; Departments of Radiotherapy and Surgery, Catharina Ziekenhuis, Eindhoven; Department of Surgery, Leyenburg Hospital, The Hague; and Department of Surgical Oncology, Groningen University Hospital, Groningen, the Netherlands
Venue
Journal of Clinical Oncology
Published
2005-09-01
Volume
23
Issue
25
Pages
6199-6206
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2149273511
Cited by
943
References
29
Citations by year
2026: 21 · 2025: 34 · 2024: 34 · 2023: 41 · 2022: 50 · 2021: 54 · 2020: 57 · 2019: 44 · 2018: 48 · 2017: 48 · 2016: 51 · 2015: 53 · 2014: 64 · 2013: 53 · 2012: 45
FWCI
18.19
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
Cancerfonden
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
  • Health Sciences › Medicine › Surgery › Colorectal and Anal Carcinomas
  • Health Sciences › Medicine › Rheumatology › Pelvic floor disorders treatments
Keywords
rectal cancer, preoperative radiotherapy, total mesorectal excision, late effects, bowel dysfunction, fecal incontinence, stoma function, urinary function, long-term morbidity, patient satisfaction
MeSH terms
Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Fecal Incontinence, Female, Follow-Up Studies, Humans, Male, Middle Aged, Morbidity, Radiation Injuries, Rectal Neoplasms, Patient Satisfaction, Dose Fractionation, Radiation, Neoadjuvant Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review